Research Article
The Importance of Clinical Data for the Diagnosis of Breast Tumours in North Afghanistan
Table 7
Incidence of benign lesions and malignant breast tumours.
| | Diagnosis | and % | Diagnosis done by cytology | ICD-10 | ICD-O |
| | Inflammatory breast diseases | | Fibrous-cystic breast disease | 73
14.5% | 44/73 (60.3%) | N60.1 | None | | Mastitis | 77
15.2% | 59/77 (80.8%) | N61 | None | | Galactorrhoe | 12
2.4% | 12/12 (100%) | N64.8 | None | | Fat necrosis | 6
1.2% | 3/6 (50%) | M78.89 | None | | Benign breast tumour | | Adenoma | 21
4.2% | 4/21 (19.0%) | D24 | 8211/0, 8204/0, 8204/0 | | Fibroadenoma | 147
29.1% | 115/147 (78.2%) | D24 | 9010/0 | | Papilloma | 8
1.6% | 6/8 (75%) | D36.9, D24X | 8503/0 | | Phyllode tumour | 7
1.4% | 1/7 (14.3%) | D24 | 9020/0, 9020/1 | | Radial scar | 3
0.6% | 0/3 (0%) | N60.2 | None | | Sclerosing adenosis | 12
2.4% | 1/12 (8.3%) | Not given | None | | Invasive breast carcinoma (IBC) | | IBC | 139
27.4% | 77/139 (55.4%) | 8500/3, 8520/3 or other specialized forms | C50.9 |
|
|
